| Literature DB >> 10491320 |
H Okuda1, S Hirai, Y Takaki, M Kamada, M Baba, N Sakai, T Kishida, S Kaneko, M Yao, S Ohno, T Shuin.
Abstract
VHL tumor suppressor protein contains two domains, alpha and beta. The alpha-domain is involved in the formation of a large protein complex suggested to be involved in ubiquitin-mediated protein degradation. However, the role of the beta-domain, which may recognize the target proteins for protein degradation, remains unknown. Here we report that the beta-domain interacts directly with atypical PKC isotypes, PKCzeta and PKClambda. Further, the regulatory domain of aPKC is sufficient for this direct protein-protein interaction. Since aPKC isotypes have been implicated in the regulation of cell growth and apoptosis, these results suggest that aPKC isotypes are potential direct target of the VHL beta-domain. Copyright 1999 Academic Press.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10491320 DOI: 10.1006/bbrc.1999.1347
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575